Nyumbani › Ugonjwa wa Crohn › California
Majaribio ya kliniki ya Ugonjwa wa Crohn katika jimbo la California
Masomo 37 ya Ugonjwa wa Crohn yanatafuta washiriki katika vituo vya jimbo la California.
Miji katika jimbo la California
- San DiegoUtafiti 15
- Los AngelesUtafiti 15
- LancasterUtafiti 7
- AnaheimUtafiti 6
- OxnardUtafiti 5
- Mountain ViewUtafiti 5
- SacramentoUtafiti 4
- San FranciscoUtafiti 4
- Santa MonicaUtafiti 4
- WestminsterUtafiti 4
- MurrietaUtafiti 4
- OrangeUtafiti 4
- EscondidoUtafiti 3
Maandishi rasmi ya utafiti (Kiingereza)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Clinnova Research ( Site 5110), Anaheim
- Southern California Research Center ( Site 5044), Coronado
- Om Research LLC ( Site 5038), Lancaster
- na zaidi ya 5
InaajiriHatua 3
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Clinnova Research /ID# 280509, Anaheim
- Southern California Res. Ctr /ID# 280476, Coronado
- Gastro Care Institute /ID# 281071, Lancaster
- na zaidi ya 2
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology and Liver Institute, Escondido
- United Clinical Research Institute, Murrieta
InaajiriHatua 4
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cedars Sinai Medical Center, Los Angeles
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Southern California Res. Ctr /ID# 265549, Coronado
- UC San Diego Health System /ID# 265565, La Jolla
- uc davis medical center - patient support services building /ID# 265554, Sacramento
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Gastro Care Institute, Lancaster
- United Gastroenterologists, Los Alamitos
- na zaidi ya 3
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Southern California Research Center, Coronado
- Om Research, LLC 1, Lancaster
- na zaidi ya 6
InaajiriHatua 2/3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- United Medical Doctors, Murrieta
- UCI Health, Orange
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- na zaidi ya 1
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Alliance Research Institute-Site Number: 8400008, Canoga Park
- Southern California GI & Liver Centers-Site Number: 8400062, Coronado
- Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido
- na zaidi ya 14
InaajiriHatua 3
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- UCSF Benioff Children's Hospital - Oakland /ID# 258327, Oakland
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Gastro Care Institute, Lancaster
- Infinity Clinical Research, San Diego
InaajiriHatua 2
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- UCSF Medical Center at Mission Bay, San Francisco
InaajiriHatua 3
Umri 2 hadi 19 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University of California San Diego Health (UCSD), La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- Hoag Hospital Newport Beach, Newport Beach
InaajiriHatua 4
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Gastro SB Clinic, Chula Vista
- United Medical Doctors, Los Alamitos
- na zaidi ya 1
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cedars Sinai Medical Center, Los Angeles
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 24 Ago 2026 · NCT05509777Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Hoag Hospital, Irvine
- UC San Diego Health, La Jolla
- Cedars-Sinai, Los Angeles
- na zaidi ya 1
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Ago 2026 · NCT05230173A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital Of Orange County, Orange
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 3 Ago 2026 · NCT06100289Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- UCSF Benioff Children's Hospital - Oakland /ID# 262217, Oakland
- Lucile Packard Children's Hospital /ID# 262193, Palo Alto
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 24 Jun 2026 · NCT06332534A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Loma Linda University, Loma Linda
- Children's Hospital of Orange County, Orange
- Stanford Children's Health, Palo Alto
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 22 Jun 2026 · NCT06405087Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Cedars-Sinai Medical Center, Beverly Hills
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 5 Jun 2026 · NCT06976853Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Cedars-Sinai, Los Angeles
- UCSF Benioff Children's Hospitals, San Francisco
InaajiriHatua 4
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 27 Mei 2026 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- UCSD Medical Center, La Jolla
- Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
InaajiriHatua 3
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 27 Mei 2026 · NCT06227910A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Rady Children's Hospital - San Diego - PIN, San Diego
InaajiriHatua 3
Umri 2 na zaidi · Jinsia zote · Imesasishwa 7 Mei 2026 · NCT05442567Precise Infliximab Exposure and Pharmacodynamic Control
- Children's Hospital of Los Angeles, Los Angeles
- Lucile Packard Children's Hospital Stanford, Palo Alto
- Rady Children's Hospital San Diego, San Diego
InaajiriHatua 2/3
Umri 6 hadi 22 · Jinsia zote · Imesasishwa 5 Mei 2026 · NCT05660746A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Rady Childrens Hospital San Diego - PIN, San Diego
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 5 Mei 2026 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Hoag Hospital, Irvine
- United Medical Doctors, Murrieta
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 27 Apr 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400005, Escondido
- Investigational Site Number: 8400001, Lancaster
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 27 Mac 2026 · NCT06958536Effect of Statins on Crohn's Disease
- Stanford University, Stanford
InaajiriHatua ya kwanza ya awali
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 27 Feb 2026 · NCT06538649Impact of Prebiotics in Ulcerative Colitis
- UCLA, Los Angeles
Inaajiri
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 27 Feb 2026 · NCT06495658Stem Cell Transplantation in Crohn's Disease
- Cedars-Sinai Medical Center, Los Angeles
InaajiriHatua 1/2
Umri 13 hadi 28 · Jinsia zote · Imesasishwa 20 Feb 2026 · NCT04224558Treatment of Moderate to Severe Refractory Crohn's Disease
- University of California, Davis, Sacramento
- University of California, San Francisco, San Francisco
InaajiriHatua 1/2
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 10 Des 2025 · NCT06721962Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
InaajiriUtafiti wa uchunguzi
Umri wote · Wanawake · Imesasishwa 28 Jan 2025 · NCT02103361Urine Metabolites in the Diagnosis of Disease
- Unio Health Partners (Gastroenterology), Encinitas
- Digestive Health Associates, Santa Monica
- Westside Gastro Care, Santa Monica
- na zaidi ya 1
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Des 2024 · NCT06710067Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.